Mycobacterium abscessus natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Infection with mycobacterium abscessus (''M. abscessus'') can lead to [[skin and soft tissue infection|Skin, soft tissues]] and [[bone]] infections, bronchopulmonary infections, and disseminated infection in non-[[AIDS]] immunocompromised patients<ref name="pmid22290346">{{cite journal| author=Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B| title=Mycobacterium abscessus: a new antibiotic nightmare. | journal=J Antimicrob Chemother | year= 2012 | volume= 67 | issue= 4 | pages= 810-8 | pmid=22290346 | doi=10.1093/jac/dkr578 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22290346  }} </ref>  Minor infections with ''M. abscessus'' can resolve either spontaneously or following surgical debridement. In the absence of therapy, abscesses that occur after injection of the organism may last up to 8 to 12 months until they resolve spontaneously.<ref name="pmid17277290">{{cite journal| author=Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al.| title=An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. | journal=Am J Respir Crit Care Med | year= 2007 | volume= 175 | issue= 4 | pages= 367-416 | pmid=17277290 | doi=10.1164/rccm.200604-571ST | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17277290  }} </ref>  The majority of pulmonary ''M. abscessus'' infection are chronic and incurable.  When pulmonary ''M. abscessus'' infection occurs in the absence of any predisposing conditions, the course of the disease is slowly progressive and indolent.  Whereas, when the pulmonary infection is associated with underlying predisposing factors, such as gastrointestinal or pulmonary conditions, the disease is rapidly progressive and fulminant.<ref name="pmid8484642">{{cite journal| author=Griffith DE, Girard WM, Wallace RJ| title=Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. | journal=Am Rev Respir Dis | year= 1993 | volume= 147 | issue= 5 | pages= 1271-8 | pmid=8484642 | doi=10.1164/ajrccm/147.5.1271 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8484642  }} </ref>
Infection with mycobacterium abscessus (''M. abscessus'') can lead to [[skin and soft tissue infection|Skin, soft tissues]] and [[bone]] infections, bronchopulmonary infections, and disseminated infection in non-[[AIDS]] immunocompromised patients<ref name="pmid22290346">{{cite journal| author=Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B| title=Mycobacterium abscessus: a new antibiotic nightmare. | journal=J Antimicrob Chemother | year= 2012 | volume= 67 | issue= 4 | pages= 810-8 | pmid=22290346 | doi=10.1093/jac/dkr578 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22290346  }} </ref>  Minor infections with ''M. abscessus'' can resolve either spontaneously or following surgical debridement.<ref name="pmid17277290">{{cite journal| author=Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al.| title=An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. | journal=Am J Respir Crit Care Med | year= 2007 | volume= 175 | issue= 4 | pages= 367-416 | pmid=17277290 | doi=10.1164/rccm.200604-571ST | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17277290  }} </ref>  The majority of pulmonary ''M. abscessus'' infection are chronic and incurable.  When pulmonary ''M. abscessus'' infection occurs in the absence of any predisposing conditions, the course of the disease is slowly progressive and indolent.  Whereas, when the pulmonary infection is associated with underlying predisposing factors, such as gastrointestinal or pulmonary conditions, the disease is rapidly progressive and fulminant.<ref name="pmid8484642">{{cite journal| author=Griffith DE, Girard WM, Wallace RJ| title=Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. | journal=Am Rev Respir Dis | year= 1993 | volume= 147 | issue= 5 | pages= 1271-8 | pmid=8484642 | doi=10.1164/ajrccm/147.5.1271 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8484642  }} </ref>


==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==

Revision as of 13:26, 24 July 2014

Mycobacterium Abscessus Microchapters

Home

Patient Information

Overview

Historical Perspective

Causes

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Case Studies

Case #1

Mycobacterium abscessus natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycobacterium abscessus natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycobacterium abscessus natural history, complications and prognosis

CDC on Mycobacterium abscessus natural history, complications and prognosis

Mycobacterium abscessus natural history, complications and prognosis in the news

Blogs on Mycobacterium abscessus natural history, complications and prognosis

Directions to Hospitals Treating Mycobacterium abscessus

Risk calculators and risk factors for Mycobacterium abscessus natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Infection with mycobacterium abscessus (M. abscessus) can lead to Skin, soft tissues and bone infections, bronchopulmonary infections, and disseminated infection in non-AIDS immunocompromised patients[1] Minor infections with M. abscessus can resolve either spontaneously or following surgical debridement.[2] The majority of pulmonary M. abscessus infection are chronic and incurable. When pulmonary M. abscessus infection occurs in the absence of any predisposing conditions, the course of the disease is slowly progressive and indolent. Whereas, when the pulmonary infection is associated with underlying predisposing factors, such as gastrointestinal or pulmonary conditions, the disease is rapidly progressive and fulminant.[3]

Natural History, Complications and Prognosis

Infection with M. abscessus can lead to:

Skin and Soft Tissue Infection

Minor infections with M. abscessus can resolve either spontaneously or following surgical debridement. In the absence of therapy, abscesses that occur after injection of the organism may last up to 8 to 12 months until they resolve spontaneously.[2]

M. abscessus hand-and-foot disease has been described in the pediatric population with wading and public pool exposure.[5][6] The disease is characterized by self limited tender, erythematous, pustules, papules, and abscesses in the hands and feet.[5][6]

Pulmonary Infection

M. abscessus is the most common non tuberculosis mycobacterial infection in cystic fibrosis.[9] Chronic infection with M. abscessus is associated with a decline in lung function among patients with cystic fibrosis.[10] The most commonly reported symptom is cough. Constitutional symptoms increase as the disease progresses. The only effective long-term therapy for M. abscessus was reported to be surgical resection of the localized disease.[3] Death may occur in these patients (mortality in ~14% of patients) due to respiratory failure secondary to the progressive lung disease.[3]

When pulmonary M. abscessus infection occurs in the absence of any predisposing conditions, the course of the disease is slowly progressive and indolent. Whereas, when the pulmonary infection is associated with underlying predisposing factors, such as gastrointestinal or pulmonary conditions, the disease is rapidly progressive and fulminant.[3]

The majority of pulmonary M. abscessus infection are chronic and incurable. Successful treatment is more likely if the disease is limited and if the patient undergoes surgical resection following the initial antibiotic therapy.[2]

References

  1. 1.0 1.1 1.2 Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B (2012). "Mycobacterium abscessus: a new antibiotic nightmare". J Antimicrob Chemother. 67 (4): 810–8. doi:10.1093/jac/dkr578. PMID 22290346.
  2. 2.0 2.1 2.2 2.3 Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F; et al. (2007). "An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases". Am J Respir Crit Care Med. 175 (4): 367–416. doi:10.1164/rccm.200604-571ST. PMID 17277290.
  3. 3.0 3.1 3.2 3.3 Griffith DE, Girard WM, Wallace RJ (1993). "Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients". Am Rev Respir Dis. 147 (5): 1271–8. doi:10.1164/ajrccm/147.5.1271. PMID 8484642.
  4. Hoffman PC, Fraser DW, Robicsek F, O'Bar PR, Mauney CU (1981). "Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex". J Infect Dis. 143 (4): 533–42. PMID 7240799.
  5. 5.0 5.1 5.2 Dytoc MT, Honish L, Shandro C, Ting PT, Chui L, Fiorillo L; et al. (2005). "Clinical, microbiological, and epidemiological findings of an outbreak of Mycobacterium abscessus hand-and-foot disease". Diagn Microbiol Infect Dis. 53 (1): 39–45. doi:10.1016/j.diagmicrobio.2005.03.010. PMID 16054324.
  6. 6.0 6.1 6.2 Sinagra JL, Kanitz EE, Cerocchi C, Cota C, Fantetti O, Prignano G; et al. (2014). "Mycobacterium abscessus hand-and-foot disease in children: rare or emerging disease?". Pediatr Dermatol. 31 (3): 292–7. doi:10.1111/pde.12333. PMID 24758202.
  7. Garcia DC, Sandoval-Sus J, Razzaq K, Young L (2013). "Vertebral osteomyelitis caused by Mycobacterium abscessus". BMJ Case Rep. 2013. doi:10.1136/bcr-2013-009597. PMID 23925676.
  8. Ding LW, Lai CC, Lee LN, Hsueh PR (2006). "Abdominal nontuberculous mycobacterial infection in a university hospital in Taiwan from 1997 to 2003". J Formos Med Assoc. 105 (5): 370–6. doi:10.1016/S0929-6646(09)60132-7. PMID 16638646.
  9. Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audigier C, Offredo C, Guillemot D, Halley S; et al. (2003). "Mycobacterium abscessus and children with cystic fibrosis". Emerg Infect Dis. 9 (12): 1587–91. doi:10.3201/eid0912.020774. PMC 3034322. PMID 14720400.
  10. Esther CR, Esserman DA, Gilligan P, Kerr A, Noone PG (2010). "Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis". J Cyst Fibros. 9 (2): 117–23. doi:10.1016/j.jcf.2009.12.001. PMC 3837580. PMID 20071249.


Template:WikiDoc Sources